Article
High price of Alzheimer's drug aducanumab sparks talk of bipartisan drug reform
Rating:
0.0
Views:
168
Likes:
1
Library:
1
Sen. Ron Wyden called the $56,000-a-year price tag for Biogen's new Alzheimer's drug aducanumab "unconscionable" and pressed for reforms.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value